Europarallel is compliant with the highest GDP standards of quality and integrity in distribution of pharmaceuticals. We use products sourced from reliable and respectable suppliers to ensure credibility, quality and traceability.
Compliance of Europarallel to all GDP requirements and procedures is being assessed on a continuous basis by regulatory audits.
The most recent internal audit of Europarallel was successfully passed in February, 2019. Europarallel is accredited to supply large international CROs.
Europarallel is a member of the Affordable Medicines Europe (AME), highlighting our commitment to the best standards in pharmaceutical distribution.
Europarallel (Dineras) has been inspected under national inspection program in accordance with Art. 77(1) of Directive 2001/83/EC transposed in the Lithuanian legislation. Inspection was conducted on 09/11/2018 and it was considered that Europarallel (Dineras) complies with the Good Distribution Practice requirements laid down in Article 84 of Directive 2001/83/EC.
Europarallel (Dineras) fully comply with all rights and obligations arising from the Falsified Medicines Directive (Directive 2011/62/EU) and the Delegated Regulation (2016/161) by 9 February 2019.